Sumitomo Mitsui Trust Holdings, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,832,467 shares of ARCT stock, worth $27.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,832,467
Previous 1,926,084
4.86%
Holding current value
$27.3 Million
Previous $20.4 Million
16.88%
% of portfolio
0.02%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding ARCT
# of Institutions
170Shares Held
25.9MCall Options Held
321KPut Options Held
120K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$69.9 Million0.12% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$39.5 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.83MShares$27.3 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$27 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.72MShares$25.5 Million0.18% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $396M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...